Not only for the drug industry, Mr. Speaker, but for the people who manufacture medical devices. I know that is hard to believe, given that the drug companies just cleaned up from the Medicare bill passed here, but they are indemnified in this bill if the FDA has approved what they are doing. Mr. Speaker, this is the same FDA that just last week threw science overboard and declined to approve a drug that has been found safe in 36 countries and by 24 of 29 scientists that studied it for the FDA. I do not trust the FDA anymore. But the FDA gives it approval, and then says citizens will have no recourse.
Louise Slaughter: “Not only for the drug industry, Mr. Speaker, but for the people who manufacture medical devices. I know that is hard to…”
Editor's note · Context
Discussing concerns about FDA approval processes and their implications for drug and medical device manufacturers.
Share
More from Louise Slaughter
I urge this panel to lend its support to this bipartisan effort so we can expose information that will inform future steps taken by Congress to improve pilot training practices and ensure passenger safety and confidence.
We have all said so many times and we believe with all our hearts that the children in this country are our most important resource.
We are talking about billions of dollars that we could save in our health care system.
Yes, so I think for a long time there has been a general sense in the antitrust world that vertical mergers are rarely bad, and in fact, may be mostly good.





